Parallel-group, multicenter, comparative study on the usefulness of nutrition therapy for patients with Crohn's disease Infliximab maintenance therapy
Not Applicable
Recruiting
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000010293
- Lead Sponsor
- Graduate School of Medical Sciences, Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
This is true even if one of the following are excluded from the scope. (1)Patients with bowel obstruction (2)Patients with short bowel syndrome (3)Patients with advanced liver and kidney failure (4)Patients with abnormal glucose metabolism, such as severe diabetes (5)Patients with congenital disorders of amino acid metabolism (6)Patients with milk protein allergy (7)Patients with stoma (8) Other patients attending physician has determined inappropriate test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative non-relapse rate at 48 weeks (Definition of relapse; as if CDAI was more than 150 and had increased more than 70 from the previous value. Cases of relapse were defined as patients who fulfill the definition of relapse at least once in determination of CDAI at every four weeks.)
- Secondary Outcome Measures
Name Time Method 1)CRP concentration in Blood 2)QOL assessment by SF-36 Other